For example, approximately 72% (21 out of 29) HNSCC patients showed high survivin expression by in tumor biopsies, which were associated with p53 expression, paclitaxel resistance, and progression (53, 54). Here, BIRC5 is linked to head and neck squamous cell carcinoma.